# Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

> **NCT06474169** · — · RECRUITING · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **OTHER:** 1 blood sample for each participant

## Key facts

- **NCT ID:** NCT06474169
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-27
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06474169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06474169, "Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06474169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*